Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure-Reference-Cited by-同舟云学术

Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure

Published:2020-07 Issue:1 Volume:73 Page:102-112
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Engelmann Cornelius,Sheikh Mohammed,Sharma Shreya,Kondo Takayuki,Loeffler-Wirth Henry,Zheng Yu Bao,Novelli Simone,Hall Andrew,Kerbert Annarein J.C.,Macnaughtan Jane,Mookerjee Rajeshwar,Habtesion Abeba,Davies Nathan,Ali Tauhid,Gupta Saurabh,Andreola Fausto,Jalan Rajiv

Funder

Takeda

German Research Foundation

Publisher

Elsevier BV

Subject

Hepatology

Reference45 articles.

1. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis;Moreau;Gastroenterology,2013

2. Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure;Engelmann;Crit Care,2018

3. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance;Albillos;J Hepatol,2014

4. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis;Michelena;Hepatology,2015

5. Recombinant alkaline phosphatase prevents acute on chronic liver failure;Engelmann;Sci Rep,2020

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The activation of TLR4-MyD88 signaling promotes hepatic dysfunction and fibrotic changes in SD rats resulting from prolonged exposure to sodium arsenite;International Immunopharmacology;2024-10

2. A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases;Cytometry Part B: Clinical Cytometry;2024-09-09

3. Baicalein upregulates macrophage TREM2 expression via TrKB-CREB1 pathway to attenuate acute inflammatory injury in acute-on-chronic liver failure;International Immunopharmacology;2024-09

4. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis;Metabolism;2024-09

5. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges;Engineering;2024-09